Small molecule antagonists of the CC chemokine receptor 4 (CCR4)
Douglas F Burdi1, Shannon Chi, Karen Mattia
1Millennium Pharmaceuticals, 40 Landsdowne Street, Cambridge, MA 02139, USA. chengburdi@yahoo.com
Abstract:
The identification, optimization, and structure-activity relationship (SAR) of small-molecule CCR4 antagonists is described. An initial screening hit with micromolar potency was identified that was optimized to sub-micromolar binding potency by enantiomer resolution, halogenation of the naphthalene ring, and extension of the alkyl chain linker between the central piperidine ring and the terminal aryl group. An antagonist was identified that showed good cross-reactivity against the mouse receptor and inhibited CCR4-based cell recruitment in dose-dependent fashion.
More Related Videos
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Chemotaxis in E. coli
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship


